Metabolic bone diseases: benefits and risks of the treatment
Rizzoli, R.
Revue Medicale Suisse 5(207): 1299-1300
2009
ISSN/ISBN: 1660-9379 PMID: 19626928 Document Number: 13536
Document emailed within 1 workday
Related Documents
Maldague, B.; Malghem, J. 1982: Intracortical bone resorption: its diagnostic value in metabolic bone diseases associated with high bone-turnover Annales de Radiologie 25(5): 333-336Tsuda, E. 2002: Osteoclastogenesis inhibitory factor (OCIF)/OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 3): 679-687
Tatarchenko, I.P.; Komarova, E.V. 2008: Idiopathic calcified aorta stenosis and the relation with disturbance in bone metabolic diseases: new approaches to pathogenesis and treatment Klinicheskaia Meditsina 86(7): 4-7
Torres, L.C.; Félix, R.; Canún, S.; Mazón, J.J. 1995: Epilepsy and pregnancy. Risks and benefits of anticonvulsant treatment Ginecologia y Obstetricia de Mexico 63: 282-286
Yoshikawa, S. 1986: Etiology and pathology of metabolic bone diseases: Paget's disease of bone and osteosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2437-2442
Silverberg, D.S.; Rotmensch, H.H.; Iaina, A. 1995: Low-dose thiazides in the treatment of hypertension: benefits and risks in perspective Journal of Human Hypertension 9(11): 869-873
First, M.R. 2001: Case 6: benefits and risks of OKT3 treatment in renal transplantation Transplantation 72(6): 1177-1178
Avanzini, F.; Alli, C. 1997: Post-infarction arterial hypertension: more benefits or more risks of the antihypertensive treatment? Giornale Italiano di Cardiologia 27(9): 936-944
Froom, P.; Hermoni, D.; Barak, M. 2003: Oral anticoagulation treatment--control, risks, benefits, and informed consent Harefuah 142(1): 56-60; 77
Morimoto, Y. 1986: Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--steroid hormone Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2391-2398
Weiss, C.M.; Robbins, G.B. 1981: Talking with patients about dental implants. Differential diagnosis and treatment planning benefits and risks Texas Dental Journal 99(1): 6-13
Soboroff, S.H.; Pappius, E.M.; Komaroff, A.L. 1984: Benefits, risks, and costs of alternative approaches to the evaluation and treatment of severe ankle sprain Clinical Orthopaedics and Related Research 183: 160-168
Yamauchi, M.; Sugimoto, T. 2019: Wnt signaling and bone metabolic diseases Clinical Calcium 29(3): 329-336
Gizzo, S.; Di Gangi, S.; Bertocco, A.; Noventa, M.; Fagherazzi, S.; Ancona, E.; Saccardi, C.; Patrelli, T.Silvio.; D'Antona, D.; Nardelli, G.Battista. 2014: Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits--systematic review of literature Reproductive Sciences 21(4): 423-431
Shiraki, M. 1986: Metabolic bone diseases: osteomalacia due to Fe or Al poisoning Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2493-2498
Ogura, Y.; Aizawa, S.; Oda, Y. 1986: Metabolic bone diseases: renal tubular acidosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2499-2506
Parkman, R. 1993: Bone marrow transplantation for immunodeficiency and metabolic diseases Leukemia 7(7): 1100-1102
Nakamura, T.; Kurokawa, T. 1986: Etiology and pathology of metabolic bone diseases: osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2409-2416
Takeuchi, Y. 2006: Metabolic bone diseases in patients with diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine 64(9): 1697-1702
Barbagallo, M. 1987: Histo-morphometry of the bone in metabolic diseases of the bones Recenti Progressi in Medicina 78(12): 566-570